参考文献: 1. Grifka-Walk HM, Jenkins BR, Kominsky DJ.Amino Acid Trp:TheFar Out lmpacts of Host and Commensal Tryptophan Metabolism.Front lmmunol.2021,12(June):1-14.doi:10.3389/fimmu.2021.653208 2. Li M,Liu S, Wang M, Hu H, Yin J, Liu C, Huang Y. Gut Microbiota Dysbiosis Associated with Bile Acid Metabolism in Neonatal Cholestasis Disease. Sci. Rep.2020,10,7686. 3. Coates MD, et al. Molecular defects in mucosal serotonin content and decreased serotonin reuptake transporter in ulcerative colitis and irritable bowel syndrome.Gastroenterology, 2004,126,1657-1664 4. Yazar A, Buyukafpar K, Polat G, et al.The urinary 5-hydroxyindole acetic acid and plasmanitric oxide levels in irritable bowel syndrome: a preliminary study. ScottMed J.2005,50,27-29 5. Dunlop SP,Coleman NS,Blackshaw E, etal. Abnormalities of 5-hydroxytryptamine metabolism in irritable bowel syndrome.Clin GastroenterolHepatol.2005,3(4): 349-357.doi:10.1016/s1542-3565(04)00726-8 6. Kennedy PJ, Cryan JF, Dinan TG, Clarke G.Kynurenine pathway metabolism and the microbiota-gut-brain axis. Neuropharmacology. 2017,112,399-412. 7. Wang J, Simonavicius N, Wu X, Swaminath G, Reagan J, Tian H, Ling L.Kynurenic acid as a ligand for orphan Gprotein-coupled receptor GPR35.J.Biol.Chem.2006,281,22021-22028 8. Keszthelyi D, Troost FJ,Jonkers DM, KruimelJW, Leue C,Masclee AAM.Decreased levels of kynurenic acid in the intestinal mucosa of lBS patients: Relation toserotonin and psychological state.J.Psychosom.Res.2013,74,501-504 9. Zhao ZH, Xin FZ, Xue Y,HuZ, Han Y, Ma F,Zhou D, Liu XL, CuiA, Liu Z, Liu Y,Gao J, Pan Q,Li Y,Fan.G.Indole-3-propionic acid inhibits gut dysbiosis and endotoxinleakage to attenuate steatohepatitis in rats.Exp Mol Med.2019,Sep 10;51(9):1-14.doi: 10.1038/s12276-019-0304-5 10.Zou J, Shen Y, Chen M, Zhang Z, Xiao S, Liu C, Wan Y,Yang L, Jiang S, Shang E,Qian D, Duan J. Lizhong. Decoction ameliorates ulcerative colitis in mice viamodulating gut microbiota and its metabolites.Appl Microbiol Biotechnol.2020Jul;104(13):5999-6012.doi:10.1007/s00253-020-10665-1 11.Roth W,Zadeh K, Vekariya R, Ge Y, Mohamadzadeh M.Tryptophan Metabolism and Gut-Brain Homeostasis. lnt J Mol Sci. 2021,Mar15;22(6):2973. doi:10.3390/ijms22062973 12.Scott SA, Fu J, Chang PV.Microbial tryptophan metabolites regulate gut barrier function via the aryl hydrocarbon receptor. Proc Natl Acad Sci U SA. 2020,Aug11;117(32):19376-19387.doi: 10.1073/pnas.2000047117 13. van Thiel lIAM,Botschuijver s, de Jonge WJ,Seppen J. Painful interactions:Microbial compounds and visceral pain.Biochim.Biophys. Acta Mol.Basis Dis.2020,1866,165534. 14.Liang H. DietaryL-Tryptophan Supplementation Enhances the Intestinal Mucosal Barrier Function in Weaned Piglets: lmplication of Tryptophan-MetabolizingMicrobiota.lnt.J.Mol.Sci.2019, 20,20 15.Peterson LW,Artis D. Intestinal epithelial cells: Regulators of barrier function and immune homeostasis. Nat.Rev.lmmunol.2014,14,141-153 16.Messori S,Trevisi P, Simongiovanni A, Priori D, Bosi P.Effect of susceptibility toenterotoxigenic Escherichia coli F4 and of dietary tryptophan on gut microbiotadiversity observed in healthy young pigs.Vet.Microbiol.2013,162,173-179